NPS and Analogues: 2017 Bill Status Update
This document provides a summary of legislation and regulation introduced during calendar year 2017 that pertains to novel psychoactive substances (“NPS”) and controlled substance analogues. The summary is divided into three categories of...
NPS and Analogues: Summary of State Laws
This document is a product of NAMSDL’s extensive review and analysis of current state laws addressing novel psychoactive substances (“NPS”) and controlled substance analogues. On a state-by-state basis, NAMSDL lays out laws pertaining to many issues,...
Integrating & Expanding Prescription Drug Monitoring Program Data: Lessons from Nine States
This report discusses the efforts of nine states to increase use of the PDMP by integrating PDMP data into health information technology.
Marijuana Comparison of State Laws Allowing Use for Medicinal Purposes
Including the ballot measures enacted during the November 2016 election, 29 states and the District of Columbia now allow persons with certain debilitating medical conditions to use, possess, purchase (in many cases), and cultivate (in some cases)...
Mandated Use of State Prescription Drug Monitoring Programs: Highlights of Key State Requirements
This summary highlights the specific circumstances in which prescribers have to review PMP data before prescribing controlled substances, treating pain, treating drug addiction, and treating injured workers.